or Try an Advanced Search...

    Hepatitis B Virus Stocks List

    Symbol Grade Name % Change
    BMY F Bristol-Myers Squibb Company -0.68
    INO D Inovio Pharmaceuticals, Inc. -3.81
    HOOK D HOOKIPA Pharma Inc. -4.92
    IONS C Ionis Pharmaceuticals, Inc. -1.14
    NTLA C Intellia Therapeutics, Inc. -3.12
    VIR C Vir Biotechnology, Inc. -5.89
    NNVC C NanoViricides, Inc. -26.36
    ABUS B Arbutus Biopharma Corporation -0.63
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Hepatitis B Immunodeficiency Infectious Diseases Hepatitis C Hepatitis C Virus Amyloid Amyloidosis Biopharmaceutical Biotechnology Cancer Coronavirus Influenza Medicine Alcohol Cholesterol Diabetes Dystrophy Ebola Genetics Hepatitis C Virus Infection

    Related ETFs - A few ETFs which own one or more of the above listed Hepatitis B Virus stocks.

    Symbol Grade Name Weight
    ARKG D ARK Genomic Revolution Multi-Sector ETF 7.71
    FTXH B First Trust Nasdaq Pharmaceuticals ETF 6.35
    GNOM C Global X Genomics & Biotechnology ETF 6.16
    GERM B ETFMG Treatments Testing and Advancements ETF 4.37
    MEDX B Horizon Kinetics Medical ETF 4.29
    View all Hepatitis B Virus ETFs...
    Compare ETFs
    Compare ARKG to FTXH Compare ARKG to MEDX Compare FTXH to MEDX

        Hepatitis B Virus Stocks Recent News

        Date Stock Title
        Jun 14 BMY EU to require additional cancer risk labeling on CAR T therapies
        Jun 14 BMY Bristol Myers (BMY) Gets FDA Nod for Label Expansion of Augtyro
        Jun 14 NTLA Intellia (NTLA) Banks on Genome Editing Pipeline Amid Rivalry
        Jun 14 NTLA Intellia Therapeutics Names Brian Goff to its Board of Directors
        Jun 13 BMY Bristol Myers gets FDA approval for Autyro for NTRK-positive cancers
        Jun 13 BMY U.S. Food and Drug Administration Approves Augtyro™ (repotrectinib), a Next-Generation Tyrosine Kinase Inhibitor (TKI), for the Treatment of Patients with NTRK-Positive Locally Advanced or Metastatic Solid Tumors
        Jun 13 BMY Bristol-Myers Squibb: Move Investing Time Horizon To 2025, At Least
        Jun 13 ABUS Ultragenyx (RARE) Moves 7.8% Higher: Will This Strength Last?
        Jun 11 BMY Bristol Myers Squibb (BMY) Beats Stock Market Upswing: What Investors Need to Know
        Jun 11 BMY Bristol-Myers Squibb: Could This Be A Value Trap? (Technical Analysis)
        Jun 11 BMY Bristol-Myers Squibb Company (BMY) Goldman Sachs 45th Annual Global Healthcare Conference
        Jun 11 NNVC Orally Administered NV-387 Results in Ideal Flat Blood Concentration Profile for Sustained Antiviral Effect
        Jun 11 NTLA Cathie Wood-Lead Ark Invest Dumps $7.6M Worth Of Robinhood Shares Amid GameStop Buzz, Bitcoin Choppiness
        Jun 9 NTLA Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought
        Jun 9 BMY Bristol Myers: Quality Fundamentals Suppressed By Interest Rates
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Hepatitis B Immunodeficiency Infectious Diseases Hepatitis C Hepatitis C Virus Amyloid Amyloidosis Biopharmaceutical Biotechnology Cancer Coronavirus Influenza Medicine Alcohol Cholesterol Diabetes Dystrophy Ebola Genetics Hepatitis C Virus Infection
        Hepatitis B Virus

        Hepatitis B virus (HBV), is a partially double-stranded DNA virus, a species of the genus Orthohepadnavirus and a member of the Hepadnaviridae family of viruses. This virus causes the disease hepatitis B.

        More about Hepatitis B Virus
        Browse All Tags